Andreas Goette

Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial

Andreas Goette, José Luís Merino, Michael D. Ezekowitz et al. · The Lancet · 2016 · 246 citations

Medicine, Cardiology, Pharmacotherapy +12

Cigarette smoking induces atrial fibrosis in humans via nicotine

Andreas Goette, Uwe Lendeckel, A. Kuchenbecker et al. · Heart · 2007 · 164 citations · Full text

Medicine, Cardiology, Pharmacology +15

A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study

Gregory Y.H. Lip, José Luís Merino, Michael D. Ezekowitz et al. · American Heart Journal · 2015 · 32 citations · Full text

Medicine, Cardiology, Pharmacotherapy +10

<b>Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN</b> vs. <b>warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study</b>

Andreas Goette, Winghan Jacqueline Kwong, Michael D. Ezekowitz et al. · EP Europace · 2018 · 18 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17